Trial intelligence / Profile preview

Surgical Comprehensive Treatment for PVTT in HCC

NCT00849264Phase 2Completed

Sponsor
Eastern Hepatobiliary Surgery Hospital
Start
Dec 2008
Primary completion
Dec 2009
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 2 trial of endostar in hepatocellular carcinoma (HCC), sponsored by Eastern Hepatobiliary Surgery Hospital. Started Dec 2008; status: completed.

02

Drugs

endostar
03

Conditions

hepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on NCT00849264.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00849264.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call